Lake Street Keeps Their Buy Rating on ClearPoint Neuro (CLPT)
We Think Shareholders Are Less Likely To Approve A Pay Rise For ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) CEO For Now
Key Insights ClearPoint Neuro to hold its Annual General Meeting on 15th of May Total pay for CEO Joe Burnett includes US$517.7k salary The overall pay is comparable to the industry average Over
Earnings Call Summary | ClearPoint Neuro(CLPT.US) Q1 2024 Earnings Conference
The following is a summary of the ClearPoint Neuro, Inc. (CLPT) Q1 2024 Earnings Call Transcript:Financial Performance:ClearPoint Neuro reported Q1 2024 total revenue of $7.6 million, a 41% increase c
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Q1 2024 Earnings Call Transcript
ClearPoint Neuro: A Strong Buy on Robust Revenue Growth and Strategic Advancements
ClearPoint Neuro, Inc. (CLPT) Q1 2024 Earnings Call Transcript
ClearPoint Neuro, Inc. (CLPT) Q1 2024 Earnings Call Transcript
Express News | ClearPoint Neuro Reaffirms FY24 Revenue $28M-$32M Vs $30.259M Est
ClearPoint Neuro | 10-Q: Quarterly report
ClearPoint Neuro Q1 2024 GAAP EPS $(0.16) Beats $(0.19) Estimate, Sales $7.639M Beat $6.994M Estimate
ClearPoint Neuro (NASDAQ:CLPT) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.19) by 15.79 percent. This is a 30.43 percent increase over losses of $(0
Earnings Flash (CLPT) CLEARPOINT NEURO Reports Q1 Revenue $7.6M, Vs. Street Est of $7M
04:30 PM EDT, 05/07/2024 (MT Newswires) -- Earnings Flash (CLPT) CLEARPOINT NEURO Reports Q1 Revenue $7.6M, vs. Street Est of $7M
ClearPoint Neuro Engages Stakeholders With Updated Presentation
Express News | Clearpoint Neuro Q1 Gross Margin 59%
ClearPoint Neuro 1Q Loss/Shr 16c >CLPT
ClearPoint Neuro 1Q Loss/Shr 16c >CLPT
Press Release: ClearPoint Neuro Reports First Quarter 2024 Results
ClearPoint Neuro Reports First Quarter 2024 Results First Quarter Revenue Growth +41%; Record Revenue Achieved SOLANA BEACH, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq:
ClearPoint Neuro Reports First Quarter 2024 Results
ClearPoint Neuro Reports First Quarter 2024 Results May 07, 2024 4:05pm EDT Download as PDF Related Documents Earnings Webcast Audio
ClearPoint Neuro (CLPT) Receives a Buy From Lake Street
ClearPoint Neuro to Present Novel Research and Exhibit at the 27th American Society of Gene & Cell Therapy Annual Meeting in Baltimore
SOLANA BEACH, Calif., May 02, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to
Clinical Laserthermia Notes US FDA Clearance for ClearPoint's Prism Bone Anchor Accessory
Clinical Laserthermia Systems (CLS-B.ST) partner ClearPoint Neuro received 510(k) approval from the US Food and Drug Administration for its Prism Bone Anchor Accessory. The approval is expected to hel
ClearPoint Gets FDA Clearance For Neurosurgical Equipment
ClearPoint Neuro (CLPT) said Monday it received 510(k) approval from the US Food and Drug Administration for its Prism Bone Anchor Accessory. The Prism Bone Anchor Accessory is designed for use with s
Express News | Clearpoint Neuro Inc - Plan to Begin Limited Market Release on Schedule in Q2, With a Full Market Release in Second Half of 2024
No Data